Navigating the Challenges in Therapeutic Antibody Development
Therapeutic Monoclonal antibodies are extremely important in modern medicine. Therapeutic antibody technologies have been effectively utilized, including humanizing mouse antibodies, using phage display libraries, and developing transgenic animals that carry human IgG genes. With existing procedures continually being improved, the Biopharma industry has gained a significant market share for targeted therapy. The top companies in antibodies focus on advancing immunotherapy and precision medicine through cutting-edge antibody research and development.